SipNose
SipNose15About
What does SipNose do?
SipNose is focused on creating innovative non-invasive direct nose-to-brain delivery systems designed to treat neurological disorders. Their flexible platform is adaptable for both clinical and home use, catering to pediatric, adult, and geriatric patients. The company has established a device master file with the FDA.
What is SipNose's revenue?
StartupHub estimates SipNose's annual revenue at $368K (range $344K to $924K, 67% confidence), based on comparable companies in the sector.
Where is SipNose headquartered?
SipNose is headquartered in San Diego, United States.
When was SipNose founded?
SipNose was founded in 2011.
What industry does SipNose operate in?
SipNose operates in Healthcare, Drug Delivery, Life Sciences, Neurology, MedTech, HealthTech.
How many employees does SipNose have?
SipNose has approximately 2 people on record.
What is SipNose's current status?
SipNose's current operating status is: Inactive.
Designs, manufactures, and markets medical devices for diabetes care, wound care, and drug delivery.
Manufacturer and supplier of laboratory consumables, instruments, and chemicals in India.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
An entrant is a company tagged Drug Delivery whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.